Lopressor® (metoprolol tartrate) – New formulation approval
April 10, 2025 - The FDA approved Validus Pharmaceuticals’ Lopressor (metoprolol tartrate) oral solution in adult patients for the treatment of hypertension, to lower blood pressure and in the long-term treatment of angina pectoris in adult patients, to reduce angina attacks and to improve exercise tolerance; and in the treatment of hemodynamically stable patients with definite or suspected myocardial infarction, to reduce the risk of cardiovascular mortality when used alone or in conjunction with intravenous metoprolol therapy.
Top